GIP program (Ipsen)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameGIP program (Ipsen)
Drug Alias NameGIP analogs (Ipsen)glucose-dependent insulinotropic polypeptide analogs (Ipsen)BIM-64158BIM-64173BIM-64152 +[9] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin release stimulants
TargetsInsulin receptor
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen SA
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A